‘Toxic Masculinity’: What Is Known about the Role of Androgen Receptors in Head and Neck Squamous Cell Carcinoma
International Journal of Molecular Sciences · 13.02.2023 · 24 (4) · 3766
DOI: 10.3390/ijms24043766 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.02.2023. Verfasst von Josipa Čonkaš und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Hereditary Cancer, Division of Molecular Medicine, Ruđer Bošković Institute, HR-10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Receptors, Androgen, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation, Terry Fox Foundation, “Young Researchers’ Career Development Project-Training of Doctoral Students” of the Croatian Science Foundation.
Abstract (Originalsprache)
Head and neck squamous cell carcinoma (HNSCC), the most prevalent cancer in the head and neck region, develops from the mucosal epithelium of the upper aerodigestive tract. Its development directly correlates with alcohol and/or tobacco consumption and infection with human papillomavirus. Interestingly, the relative risk for HNSCC is up to five times higher in males, so it is considered that the endocrine microenvironment is another risk factor. A gender-specific risk for HNSCC suggests either the existence of specific risk factors that affect only males or that females have defensive hormonal and metabolic features. In this review, we summarized the current knowledge about the role of both nuclear and membrane androgen receptors (nAR and mARs, respectively) in HNSCC. As expected, the significance of nAR is much better known; it was shown that increased nAR expression was observed in HNSCC, while treatment with dihydrotestosterone increased proliferation, migration, and invasion of HNSCC cells. For only three out of five currently known mARs—TRPM8, CaV1.2, and OXER1—it was shown either their increased expression in various types of HNSCC or that their increased activity enhanced the migration and invasion of HNSCC cells. The primary treatments for HNSCC are surgery and radiotherapy, but targeted immunotherapies are on the rise. On the other hand, given the evidence of elevated nAR expression in HNSCC, this receptor represents a potential target for antiandrogen therapy. Moreover, there is still plenty of room for further examination of mARs’ role in HNSCC diagnosis, prognosis, and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Hereditary Cancer, Division of Molecular Medicine, Ruđer Bošković Institute, HR-10000 Zagreb, Croatia.
ORCID-Profile: Josipa Čonkaš, Maja Sabol, Petar Ozretić
Förderung
- Croatian Science Foundation
- Terry Fox Foundation
- “Young Researchers’ Career Development Project-Training of Doctoral Students” of the Croatian Science Foundation
Zitieren
APA
Čonkaš, J., Sabol, M., & Ozretić, P. (2023). ‘Toxic Masculinity’: What Is Known about the Role of Androgen Receptors in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences, 24(4), 3766. https://doi.org/10.3390/ijms24043766
Vancouver
Čonkaš J, Sabol M, Ozretić P. ‘Toxic Masculinity’: What Is Known about the Role of Androgen Receptors in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2023;24(4):3766. doi:10.3390/ijms24043766
BibTeX
@article{onka2023,
author = {Čonkaš, Josipa and Sabol, Maja and Ozretić, Petar},
title = {‘Toxic Masculinity’: What Is Known about the Role of Androgen Receptors in Head and Neck Squamous Cell Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3766},
doi = {10.3390/ijms24043766}
}
EUVIMED